My latest for @Medscape delves into how MDs are coping with the ACA subsidy gap-right now:
medscape.com/viewarticle/ac…
medscape.com/viewarticle/ac…
@LambethHochwald
His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy -- and he almost never found out. wb.md/49TTsuwView quoted post on X